Raymond James & Associates’s Benefitfocus, Inc. BNFT Stock Holding History

Raymond James & Associates’s Portfolio BNFT Stock Details BNFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,600	Closed	-$52K	–	3750
2018 Q2	$52K	Buy	+10,600	New	+$332K	﹤0.01%	3439
2017 Q4	–	Sell	-12,900	Closed	-$22K	–	3559
2017 Q3	$22K	Sell	12,900 -2,800	-18%	-$89.6K	﹤0.01%	3307
2017 Q2	$52K	Buy	+15,700	New	+$504K	﹤0.01%	3182
2017 Q1	–	Sell	-13,000	Closed	-$8K	–	3426
2016 Q4	$8K	Buy	13,000 +2,000	+18%	+$63.8K	﹤0.01%	3200
2016 Q3	$35K	Buy	+11,000	New	+$451K	﹤0.01%	3108
2016 Q2	–	Sell	-15,400	Closed	-$18K	–	3107
2016 Q1	$18K	Buy	+15,400	New	+$459K	﹤0.01%	2866

Other funds holding BNFT

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Raymond James & Associates's BNFT Position: Q1 2023 in Review

Raymond James & Associates sold out of Benefitfocus, Inc. (BNFT) in Q1 2023, closing a stake of 21,858 shares — an estimated $229K sold.

Raymond James & Associates first reported a position in BNFT in Q3 2014 and held it in 34 quarters. The position peaked at $13M in Q1 2019. 1 fund tracked by Wall St. Rank holds BNFT as of Q1 2023.

Raymond James & Associates reported no remaining Benefitfocus, Inc. position as of Q1 2023 after selling out during the quarter.
Raymond James & Associates sold 21,858 Benefitfocus, Inc. shares in Q1 2023, an estimated $229K.
Raymond James & Associates first reported a position in Benefitfocus, Inc. in Q3 2014 and held it in 34 quarters.
Raymond James & Associates's Benefitfocus, Inc. position peaked at $13M in Q1 2019.
1 fund tracked by Wall St. Rank held Benefitfocus, Inc. as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.